Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2013007934
pages 449-461

Iron in Multiple Myeloma

Kristina VanderWall
Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine
Tracy R. Daniels-Wells
Division of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine
Manuel Penichet
Division of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine; The Jonsson Comprehensive Cancer Center, The Molecular Biology Institute, Department of Microbiology, Immunology, and Molecular Genetics, UCLA
Alan Llichtenstein
Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine; The Jonsson Comprehensive Cancer Center, UCLA; The Greater Los Angeles VA Medical Center, Los Angeles, California

RESUMO

Multiple myeloma is a non-curable B-cell malignancy in which iron metabolism plays an important role. Patients with this disorder almost universally suffer from clinically significant anemia, which is often symptomatic, and which is due to impaired iron utilization. Recent studies have indicated that the proximal cause of dysregulated iron metabolism and anemia in these patients is cytokine-induced upregulation of hepcidin expression. Malignant myeloma cells are dependent on an increased influx of iron, and therapeutic efforts are being made to target this requirement. The studies detailing the characteristics and biochemical abnormalities in iron metabolism causing anemia and the initial attempts to target iron therapeutically are described in this review.


Articles with similar content:

Mechanisms of Metastasis as Related to Receptor Tyrosine Kinases in Small-Cell Lung Cancer
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 3
Patrick C. Ma, Ravi Salgia, Nazia F. Jafri
Signaling Pathways in Pancreatic Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 2
Meir Preis , Murray Korc
Kruppel-Like Factor 4: From Physiological Functions to Tumor Therapy
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Peng Li, Ruocong Zhao, Yunxin Lai
Microenvironmental Hypoxia Orchestrating the Cell Stroma Cross Talk, Tumor Progression and Antitumor Response
Critical Reviews™ in Immunology, Vol.31, 2011, issue 5
Muhammad Zaeem Noman, Yosra Messai, Thibault Carre, Salem Chouaib, Bassam Janji, Meriem Hasmim, Intissar Akalay, Marine Meron
Surveillance of HPV-Positive Head and Neck Squamous Cell Carcinoma with Circulating and Salivary DNA Biomarkers
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Jordan Cheng, Shreerang Bhide, Hisham Mehanna, Paul Nankivell, Yong Kim, Feng Li, David Wong, Nikolas Batis, Kanishka Rao, Daniele Borsetto, Karl Payne